Click here to read this study in the Lancet. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be ...
1. Return to baseline function was comparable in tenecteplase and standard-of-care groups. 2. More deaths and intracranial hemorrhages were reported ...
1. In a randomized controlled trial of patients who suffered an acute ischemic stroke, the reteplase group reported a greater ...
1. The 90-day modified Ranking Scale score was comparable for patients in intravenous thrombolysis plus endovascular treatment versus endovascular treatment ...
1. The 90-day modified Ranking Scale score was comparable for patients in intravenous thrombolysis plus endovascular treatment versus endovascular treatment ...
1. The ARAMIS trial revealed that the rate of favourable neurologic function at 90 days was 93.8% among patients assigned ...
1. The ARAMIS trial revealed that the rate of favourable neurologic function at 90 days was 93.8% among patients assigned ...
1. A similar proportion of patients in the alteplase group reported a modified Rankin Scale score of 0-1 compared to ...
Click here to read this study in NEJM
![The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]](data:image/svg+xml;nitro-empty-id=NzI3OjE0MzA=-1;base64,PHN2ZyB2aWV3Qm94PSIwIDAgMSAxIiB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==)
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark ...
